newsfilter
← Latest News
Business Wire·

Graphite Bio Reports Recent Business Progress and Third Quarter 2022 Financial Results

Dosed first sickle cell patient with nula-cel; initial proof-of-concept data on track for mid-2023 Two abstracts accepted for 64th ASH Annual Meeting and Exposition in December Entered strategic partnership with